Hirschsprung disease, associated syndromes, and genetics: a review (original) (raw)

Abstract

Hirschsprung disease (HSCR, aganglionic megacolon) is the main genetic cause of functional intestinal obstruction with an incidence of 1/5000 live births. This developmental disorder is a neurocristopathy and is characterised by the absence of the enteric ganglia along a variable length of the intestine. In the last decades, the development of surgical approaches has dramatically decreased mortality and morbidity, which has allowed the emergence of familial cases. HSCR appeared to be a multifactorial malformation with low, sex dependent penetrance and variable expression according to the length of the aganglionic segment, suggesting the involvement of one or more gene(s) with low penetrance. So far, eight genes have been found to be involved in HSCR. This frequent congenital malformation now stands as a model for genetic disorders with complex patterns of inheritance. Keywords: Hirschsprung disease; aganglionic megacolon; genetics

Full Text

The Full Text of this article is available as a PDF (167.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albanese C. T., Jennings R. W., Smith B., Bratton B., Harrison M. R. Perineal one-stage pull-through for Hirschsprung's disease. J Pediatr Surg. 1999 Mar;34(3):377–380. doi: 10.1016/s0022-3468(99)90480-3. [DOI] [PubMed] [Google Scholar]
  2. Amiel J., Attié T., Jan D., Pelet A., Edery P., Bidaud C., Lacombe D., Tam P., Simeoni J., Flori E. Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet. 1996 Mar;5(3):355–357. doi: 10.1093/hmg/5.3.355. [DOI] [PubMed] [Google Scholar]
  3. Amiel J., Salomon R., Attié T., Pelet A., Trang H., Mokhtari M., Gaultier C., Munnich A., Lyonnet S. Mutations of the RET-GDNF signaling pathway in Ondine's curse. Am J Hum Genet. 1998 Mar;62(3):715–717. doi: 10.1086/301759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Angrist M., Bolk S., Halushka M., Lapchak P. A., Chakravarti A. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient. Nat Genet. 1996 Nov;14(3):341–344. doi: 10.1038/ng1196-341. [DOI] [PubMed] [Google Scholar]
  5. Angrist M., Bolk S., Thiel B., Puffenberger E. G., Hofstra R. M., Buys C. H., Cass D. T., Chakravarti A. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet. 1995 May;4(5):821–830. doi: 10.1093/hmg/4.5.821. [DOI] [PubMed] [Google Scholar]
  6. Angrist M., Jing S., Bolk S., Bentley K., Nallasamy S., Halushka M., Fox G. M., Chakravarti A. Human GFRA1: cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility. Genomics. 1998 Mar 15;48(3):354–362. doi: 10.1006/geno.1997.5191. [DOI] [PubMed] [Google Scholar]
  7. Angrist M., Kauffman E., Slaugenhaupt S. A., Matise T. C., Puffenberger E. G., Washington S. S., Lipson A., Cass D. T., Reyna T., Weeks D. E. A gene for Hirschsprung disease (megacolon) in the pericentromeric region of human chromosome 10. Nat Genet. 1993 Aug;4(4):351–356. doi: 10.1038/ng0893-351. [DOI] [PubMed] [Google Scholar]
  8. Attié T., Pelet A., Edery P., Eng C., Mulligan L. M., Amiel J., Boutrand L., Beldjord C., Nihoul-Fékété C., Munnich A. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet. 1995 Aug;4(8):1381–1386. doi: 10.1093/hmg/4.8.1381. [DOI] [PubMed] [Google Scholar]
  9. Attié T., Till M., Pelet A., Amiel J., Edery P., Boutrand L., Munnich A., Lyonnet S. Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet. 1995 Dec;4(12):2407–2409. doi: 10.1093/hmg/4.12.2407. [DOI] [PubMed] [Google Scholar]
  10. Auricchio A., Casari G., Staiano A., Ballabio A. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum Mol Genet. 1996 Mar;5(3):351–354. doi: 10.1093/hmg/5.3.351. [DOI] [PubMed] [Google Scholar]
  11. Auricchio A., Griseri P., Carpentieri M. L., Betsos N., Staiano A., Tozzi A., Priolo M., Thompson H., Bocciardi R., Romeo G. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. Am J Hum Genet. 1999 Apr;64(4):1216–1221. doi: 10.1086/302329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Badner J. A., Sieber W. K., Garver K. L., Chakravarti A. A genetic study of Hirschsprung disease. Am J Hum Genet. 1990 Mar;46(3):568–580. [PMC free article] [PubMed] [Google Scholar]
  13. Baloh R. H., Tansey M. G., Lampe P. A., Fahrner T. J., Enomoto H., Simburger K. S., Leitner M. L., Araki T., Johnson E. M., Jr, Milbrandt J. Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron. 1998 Dec;21(6):1291–1302. doi: 10.1016/s0896-6273(00)80649-2. [DOI] [PubMed] [Google Scholar]
  14. Baynash A. G., Hosoda K., Giaid A., Richardson J. A., Emoto N., Hammer R. E., Yanagisawa M. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell. 1994 Dec 30;79(7):1277–1285. doi: 10.1016/0092-8674(94)90018-3. [DOI] [PubMed] [Google Scholar]
  15. Bidaud C., Salomon R., Van Camp G., Pelet A., Attié T., Eng C., Bonduelle M., Amiel J., Nihoul-Fékété C., Willems P. J. Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur J Hum Genet. 1997 Jul-Aug;5(4):247–251. [PubMed] [Google Scholar]
  16. Bolk S., Angrist M., Xie J., Yanagisawa M., Silvestri J. M., Weese-Mayer D. E., Chakravarti A. Endothelin-3 frameshift mutation in congenital central hypoventilation syndrome. Nat Genet. 1996 Aug;13(4):395–396. doi: 10.1038/ng0896-395. [DOI] [PubMed] [Google Scholar]
  17. Bolk S., Pelet A., Hofstra R. M., Angrist M., Salomon R., Croaker D., Buys C. H., Lyonnet S., Chakravarti A. A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):268–273. doi: 10.1073/pnas.97.1.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bondurand N., Kuhlbrodt K., Pingault V., Enderich J., Sajus M., Tommerup N., Warburg M., Hennekam R. C., Read A. P., Wegner M. A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum Mol Genet. 1999 Sep;8(9):1785–1789. doi: 10.1093/hmg/8.9.1785. [DOI] [PubMed] [Google Scholar]
  19. Borrego S., Eng C., Sánchez B., Sáez M. E., Navarro E., Antiñolo G. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab. 1998 Sep;83(9):3361–3364. doi: 10.1210/jcem.83.9.5093. [DOI] [PubMed] [Google Scholar]
  20. Borrego S., Ruiz A., Saez M. E., Gimm O., Gao X., López-Alonso M., Hernández A., Wright F. A., Antiñolo G., Eng C. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease. J Med Genet. 2000 Aug;37(8):572–578. doi: 10.1136/jmg.37.8.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Borrego S., Sáez M. E., Ruiz A., Gimm O., López-Alonso M., Antiñolo G., Eng C. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression. J Med Genet. 1999 Oct;36(10):771–774. doi: 10.1136/jmg.36.10.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Borst M. J., VanCamp J. M., Peacock M. L., Decker R. A. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. Surgery. 1995 Apr;117(4):386–391. doi: 10.1016/s0039-6060(05)80057-1. [DOI] [PubMed] [Google Scholar]
  23. Bottani A., Xie Y. G., Binkert F., Schinzel A. A case of Hirschsprung disease with a chromosome 13 microdeletion, del(13)(q32.3q33.2): potential mapping of one disease locus. Hum Genet. 1991 Oct;87(6):748–750. doi: 10.1007/BF00201741. [DOI] [PubMed] [Google Scholar]
  24. Cacalano G., Fariñas I., Wang L. C., Hagler K., Forgie A., Moore M., Armanini M., Phillips H., Ryan A. M., Reichardt L. F. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron. 1998 Jul;21(1):53–62. doi: 10.1016/s0896-6273(00)80514-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Carlomagno F., De Vita G., Berlingieri M. T., de Franciscis V., Melillo R. M., Colantuoni V., Kraus M. H., Di Fiore P. P., Fusco A., Santoro M. Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J. 1996 Jun 3;15(11):2717–2725. [PMC free article] [PubMed] [Google Scholar]
  26. Carlson K. M., Dou S., Chi D., Scavarda N., Toshima K., Jackson C. E., Wells S. A., Jr, Goodfellow P. J., Donis-Keller H. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1579–1583. doi: 10.1073/pnas.91.4.1579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Caron P., Attié T., David D., Amiel J., Brousset F., Roger P., Munnich A., Lyonnet S. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease. J Clin Endocrinol Metab. 1996 Jul;81(7):2731–2733. doi: 10.1210/jcem.81.7.8675603. [DOI] [PubMed] [Google Scholar]
  28. Ceccherini I., Bocciardi R., Luo Y., Pasini B., Hofstra R., Takahashi M., Romeo G. Exon structure and flanking intronic sequences of the human RET proto-oncogene. Biochem Biophys Res Commun. 1993 Nov 15;196(3):1288–1295. doi: 10.1006/bbrc.1993.2392. [DOI] [PubMed] [Google Scholar]
  29. Chakravarti A. Endothelin receptor-mediated signaling in hirschsprung disease. Hum Mol Genet. 1996 Mar;5(3):303–307. [PubMed] [Google Scholar]
  30. Chatten J., Voorhess M. L. Familial neuroblastoma. Report of a kindred with multiple disorders, including neuroblastomas in four siblings. N Engl J Med. 1967 Dec 7;277(23):1230–1236. doi: 10.1056/NEJM196712072772304. [DOI] [PubMed] [Google Scholar]
  31. Clausen N., Andersson P., Tommerup N. Familial occurrence of neuroblastoma, von Recklinghausen's neurofibromatosis, Hirschsprung's agangliosis and jaw-winking syndrome. Acta Paediatr Scand. 1989 Sep;78(5):736–741. doi: 10.1111/j.1651-2227.1989.tb11135.x. [DOI] [PubMed] [Google Scholar]
  32. Cohen I. T., Gadd M. A. Hirschsprung's disease in a kindred: a possible clue to the genetics of the disease. J Pediatr Surg. 1982 Oct;17(5):632–634. doi: 10.1016/s0022-3468(82)80124-3. [DOI] [PubMed] [Google Scholar]
  33. Davenport M., Taitz L. S., Dickson J. A. The Kaufman-McKusick syndrome: another association. J Pediatr Surg. 1989 Nov;24(11):1192–1194. doi: 10.1016/s0022-3468(89)80118-6. [DOI] [PubMed] [Google Scholar]
  34. Decker R. A., Peacock M. L., Watson P. Hirschsprung disease in MEN 2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum Mol Genet. 1998 Jan;7(1):129–134. doi: 10.1093/hmg/7.1.129. [DOI] [PubMed] [Google Scholar]
  35. Donis-Keller H., Dou S., Chi D., Carlson K. M., Toshima K., Lairmore T. C., Howe J. R., Moley J. F., Goodfellow P., Wells S. A., Jr Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993 Jul;2(7):851–856. doi: 10.1093/hmg/2.7.851. [DOI] [PubMed] [Google Scholar]
  36. Doray B., Salomon R., Amiel J., Pelet A., Touraine R., Billaud M., Attié T., Bachy B., Munnich A., Lyonnet S. Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet. 1998 Sep;7(9):1449–1452. doi: 10.1093/hmg/7.9.1449. [DOI] [PubMed] [Google Scholar]
  37. Durbec P., Marcos-Gutierrez C. V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 1996 Jun 27;381(6585):789–793. doi: 10.1038/381789a0. [DOI] [PubMed] [Google Scholar]
  38. Edery P., Attié T., Amiel J., Pelet A., Eng C., Hofstra R. M., Martelli H., Bidaud C., Munnich A., Lyonnet S. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet. 1996 Apr;12(4):442–444. doi: 10.1038/ng0496-442. [DOI] [PubMed] [Google Scholar]
  39. Edery P., Lyonnet S., Mulligan L. M., Pelet A., Dow E., Abel L., Holder S., Nihoul-Fékété C., Ponder B. A., Munnich A. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):378–380. doi: 10.1038/367378a0. [DOI] [PubMed] [Google Scholar]
  40. Emir H., Akman M., Sarimurat N., Kiliç N., Erdoğan E., Söylet Y. Anorectal manometry during the neonatal period: its specificity in the diagnosis of Hirschsprung's disease. Eur J Pediatr Surg. 1999 Apr;9(2):101–103. doi: 10.1055/s-2008-1072221. [DOI] [PubMed] [Google Scholar]
  41. Eng C., Smith D. P., Mulligan L. M., Nagai M. A., Healey C. S., Ponder M. A., Gardner E., Scheumann G. F., Jackson C. E., Tunnacliffe A. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet. 1994 Feb;3(2):237–241. doi: 10.1093/hmg/3.2.237. [DOI] [PubMed] [Google Scholar]
  42. Enomoto H., Araki T., Jackman A., Heuckeroth R. O., Snider W. D., Johnson E. M., Jr, Milbrandt J. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron. 1998 Aug;21(2):317–324. doi: 10.1016/s0896-6273(00)80541-3. [DOI] [PubMed] [Google Scholar]
  43. Fewtrell M. S., Tam P. K., Thomson A. H., Fitchett M., Currie J., Huson S. M., Mulligan L. M. Hirschsprung's disease associated with a deletion of chromosome 10 (q11.2q21.2): a further link with the neurocristopathies? J Med Genet. 1994 Apr;31(4):325–327. doi: 10.1136/jmg.31.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Gaisie G., Oh K. S., Young L. W. Coexistent neuroblastoma and Hirschsprung's disease--another manifestation of the neurocristopathy? Pediatr Radiol. 1979 Jul 24;8(3):161–163. doi: 10.1007/BF00973826. [DOI] [PubMed] [Google Scholar]
  45. Garver K. L., Law J. C., Garver B. Hirschsprung disease: a genetic study. Clin Genet. 1985 Dec;28(6):503–508. doi: 10.1111/j.1399-0004.1985.tb00417.x. [DOI] [PubMed] [Google Scholar]
  46. Goldberg E. L. An epidemiological study of Hirschsprung's disease. Int J Epidemiol. 1984 Dec;13(4):479–485. doi: 10.1093/ije/13.4.479. [DOI] [PubMed] [Google Scholar]
  47. Goldberg R. B., Shprintzen R. J. Hirschsprung megacolon and cleft palate in two sibs. J Craniofac Genet Dev Biol. 1981;1(2):185–189. [PubMed] [Google Scholar]
  48. Gozal D. Congenital central hypoventilation syndrome: an update. Pediatr Pulmonol. 1998 Oct;26(4):273–282. doi: 10.1002/(sici)1099-0496(199810)26:4<273::aid-ppul7>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  49. Gross A., Kunze J., Maier R. F., Stoltenburg-Didinger G., Grimmer I., Obladen M. Autosomal-recessive neural crest syndrome with albinism, black lock, cell migration disorder of the neurocytes of the gut, and deafness: ABCD syndrome. Am J Med Genet. 1995 Apr 10;56(3):322–326. doi: 10.1002/ajmg.1320560322. [DOI] [PubMed] [Google Scholar]
  50. Hackam D. J., Filler R. M., Pearl R. H. Enterocolitis after the surgical treatment of Hirschsprung's disease: risk factors and financial impact. J Pediatr Surg. 1998 Jun;33(6):830–833. doi: 10.1016/s0022-3468(98)90652-2. [DOI] [PubMed] [Google Scholar]
  51. Haddad G. G., Mazza N. M., Defendini R., Blanc W. A., Driscoll J. M., Epstein M. A., Epstein R. A., Mellins R. B. Congenital failure of automatic control of ventilation, gastrointestinal motility and heart rate. Medicine (Baltimore) 1978 Nov;57(6):517–526. doi: 10.1097/00005792-197811000-00003. [DOI] [PubMed] [Google Scholar]
  52. Hageman M. J., Delleman J. W. Heterogeneity in Waardenburg syndrome. Am J Hum Genet. 1977 Sep;29(5):468–485. [PMC free article] [PubMed] [Google Scholar]
  53. Halal F., Morel J. The syndrome of Hirschsprung disease, microcephaly, unusual face, and mental retardation. Am J Med Genet. 1990 Sep;37(1):106–108. doi: 10.1002/ajmg.1320370125. [DOI] [PubMed] [Google Scholar]
  54. Hall C. M. Werner's mesomelic dysplasia with ventricular septal defect and Hirschsprung's disease. Pediatr Radiol. 1981;10(4):247–249. doi: 10.1007/BF01001593. [DOI] [PubMed] [Google Scholar]
  55. Hansford J. R., Mulligan L. M. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet. 2000 Nov;37(11):817–827. doi: 10.1136/jmg.37.11.817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Herbarth B., Pingault V., Bondurand N., Kuhlbrodt K., Hermans-Borgmeyer I., Puliti A., Lemort N., Goossens M., Wegner M. Mutation of the Sry-related Sox10 gene in Dominant megacolon, a mouse model for human Hirschsprung disease. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5161–5165. doi: 10.1073/pnas.95.9.5161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Hofstra R. M., Landsvater R. M., Ceccherini I., Stulp R. P., Stelwagen T., Luo Y., Pasini B., Höppener J. W., van Amstel H. K., Romeo G. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 1994 Jan 27;367(6461):375–376. doi: 10.1038/367375a0. [DOI] [PubMed] [Google Scholar]
  58. Hofstra R. M., Osinga J., Tan-Sindhunata G., Wu Y., Kamsteeg E. J., Stulp R. P., van Ravenswaaij-Arts C., Majoor-Krakauer D., Angrist M., Chakravarti A. A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet. 1996 Apr;12(4):445–447. doi: 10.1038/ng0496-445. [DOI] [PubMed] [Google Scholar]
  59. Hofstra R. M., Valdenaire O., Arch E., Osinga J., Kroes H., Löffler B. M., Hamosh A., Meijers C., Buys C. H. A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet. 1999 Jan;64(1):304–308. doi: 10.1086/302184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Hosoda K., Hammer R. E., Richardson J. A., Baynash A. G., Cheung J. C., Giaid A., Yanagisawa M. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell. 1994 Dec 30;79(7):1267–1276. doi: 10.1016/0092-8674(94)90017-5. [DOI] [PubMed] [Google Scholar]
  61. Huang T., Elias E. R., Mulliken J. B., Kirse D. J., Holmes L. B. A new syndrome: heart defects, laryngeal anomalies, preaxial polydactyly, and colonic aganglionosis in sibs. Genet Med. 1999 Mar-Apr;1(3):104–108. doi: 10.1097/00125817-199903000-00008. [DOI] [PubMed] [Google Scholar]
  62. Hurst J. A., Markiewicz M., Kumar D., Brett E. M. Unknown syndrome: Hirschsprung's disease, microcephaly, and iris coloboma: a new syndrome of defective neuronal migration. J Med Genet. 1988 Jul;25(7):494–497. doi: 10.1136/jmg.25.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Ikeda K., Goto S. Additional anomalies in Hirschsprung's disease: an analysis based on the nationwide survey in Japan. Z Kinderchir. 1986 Oct;41(5):279–281. doi: 10.1055/s-2008-1043359. [DOI] [PubMed] [Google Scholar]
  64. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Ivanchuk S. M., Myers S. M., Eng C., Mulligan L. M. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Hum Mol Genet. 1996 Dec;5(12):2023–2026. doi: 10.1093/hmg/5.12.2023. [DOI] [PubMed] [Google Scholar]
  66. Jacobs J. M., Wilson J. An unusual demyelinating neuropathy in a patient with Waardenburg's syndrome. Acta Neuropathol. 1992;83(6):670–674. doi: 10.1007/BF00299420. [DOI] [PubMed] [Google Scholar]
  67. Janik J. P., Wayne E. R., Janik J. S., Price M. R. Ileal atresia with total colonic aganglionosis. J Pediatr Surg. 1997 Oct;32(10):1502–1503. doi: 10.1016/s0022-3468(97)90576-5. [DOI] [PubMed] [Google Scholar]
  68. Jasonni V., Martucciello G. Total colonic aganglionosis. Semin Pediatr Surg. 1998 Aug;7(3):174–180. doi: 10.1016/s1055-8586(98)70014-9. [DOI] [PubMed] [Google Scholar]
  69. Jing S., Wen D., Yu Y., Holst P. L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996 Jun 28;85(7):1113–1124. doi: 10.1016/s0092-8674(00)81311-2. [DOI] [PubMed] [Google Scholar]
  70. Kaplan P. X linked recessive inheritance of agenesis of the corpus callosum. J Med Genet. 1983 Apr;20(2):122–124. doi: 10.1136/jmg.20.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Kaplan P., de Chaderévian J. P. Piebaldism-Waardenburg syndrome: histopathologic evidence for a neural crest syndrome. Am J Med Genet. 1988 Nov;31(3):679–688. doi: 10.1002/ajmg.1320310324. [DOI] [PubMed] [Google Scholar]
  72. Kim J. J., Armstrong D. D., Fishman M. A. Multicore myopathy, microcephaly, aganglionosis, and short stature. J Child Neurol. 1994 Jul;9(3):275–277. doi: 10.1177/088307389400900309. [DOI] [PubMed] [Google Scholar]
  73. Kiss P., Osztovics M. Association of 13q deletion and Hirschsprung's disease. J Med Genet. 1989 Dec;26(12):793–794. doi: 10.1136/jmg.26.12.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Kotzbauer P. T., Lampe P. A., Heuckeroth R. O., Golden J. P., Creedon D. J., Johnson E. M., Jr, Milbrandt J. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature. 1996 Dec 5;384(6608):467–470. doi: 10.1038/384467a0. [DOI] [PubMed] [Google Scholar]
  75. Kurer M. H., Lawson J. O., Pambakian H. Suction biopsy in Hirschsprung's disease. Arch Dis Child. 1986 Jan;61(1):83–84. doi: 10.1136/adc.61.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Kusafuka T., Wang Y., Puri P. Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease. Hum Mol Genet. 1996 Mar;5(3):347–349. doi: 10.1093/hmg/5.3.347. [DOI] [PubMed] [Google Scholar]
  77. Lamont M. A., Fitchett M., Dennis N. R. Interstitial deletion of distal 13q associated with Hirschsprung's disease. J Med Genet. 1989 Feb;26(2):100–104. doi: 10.1136/jmg.26.2.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Lane P. W., Liu H. M. Association of megacolon with a new dominant spotting gene (Dom) in the mouse. J Hered. 1984 Nov-Dec;75(6):435–439. doi: 10.1093/oxfordjournals.jhered.a109980. [DOI] [PubMed] [Google Scholar]
  79. Laurence K. M., Prosser R., Rocker I., Pearson J. F., Richard C. Hirschsprung's disease associated with congenital heart malformation, broad big toes, and ulnar polydactyly in sibs: a case for fetoscopy. J Med Genet. 1975 Dec;12(4):334–338. doi: 10.1136/jmg.12.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Levard G., Boige N., Vitoux C., Aigrain Y., Boureau M., Navarro J. Neurocristopathie. Association "Maladie de Hirschsprung-ganglioneuromes et dysfonctionnement du système nerveux autonome" chez 2 enfants. Arch Fr Pediatr. 1989 Oct;46(8):595–597. [PubMed] [Google Scholar]
  81. Lorda-Sanchez I., Ayuso C., Ibañez A. Situs inversus and hirschsprung disease: two uncommon manifestations in Bardet-Biedl syndrome. Am J Med Genet. 2000 Jan 3;90(1):80–81. doi: 10.1002/(sici)1096-8628(20000103)90:1<80::aid-ajmg14>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  82. Lurie I. W., Supovitz K. R., Rosenblum-Vos L. S., Wulfsberg E. A. Phenotypic variability of del(2) (q22-q23): report of a case with a review of the literature. Genet Couns. 1994;5(1):11–14. [PubMed] [Google Scholar]
  83. Lyonnet S., Bolino A., Pelet A., Abel L., Nihoul-Fékété C., Briard M. L., Mok-Siu V., Kaariainen H., Martucciello G., Lerone M. A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet. 1993 Aug;4(4):346–350. doi: 10.1038/ng0893-346. [DOI] [PubMed] [Google Scholar]
  84. López-Alonso M., Ribas J., Hernández A., Anguita F. A., Gómez de Terreros I., Martínez-Caro A. Efficiency of the anorectal manometry for the diagnosis of Hirschsprung's disease in the newborn period. Eur J Pediatr Surg. 1995 Jun;5(3):160–163. doi: 10.1055/s-2008-1066194. [DOI] [PubMed] [Google Scholar]
  85. Mahakrishnan A., Srinivasan M. S. Piebaldness with Hirschsprung's disease. Arch Dermatol. 1980 Oct;116(10):1102–1102. [PubMed] [Google Scholar]
  86. Mallory S. B., Haynie L. S., Williams M. L., Hall W. Ichthyosis, deafness, and Hirschsprung's disease. Pediatr Dermatol. 1989 Mar;6(1):24–27. doi: 10.1111/j.1525-1470.1989.tb00262.x. [DOI] [PubMed] [Google Scholar]
  87. Mandel H., Brik R., Ludatscher R., Braun J., Berant M. Congenital muscular dystrophy with neurological abnormalities: association with Hirschsprung disease. Am J Med Genet. 1993 Aug 1;47(1):37–40. doi: 10.1002/ajmg.1320470108. [DOI] [PubMed] [Google Scholar]
  88. McMilin K. D., Reiss J. A., Brown M. G., Black M. H., Buckmaster D. A., Durum C. T., Gunter K. A., Lawce H. J., Berry T. L., Lamb O. A. Clinical outcomes of four patients with microdeletion in the long arm of chromosome 2. Am J Med Genet. 1998 Jun 16;78(1):36–43. [PubMed] [Google Scholar]
  89. Meier-Ruge W., Lutterbeck P. M., Herzog B., Morger R., Moser R., Schärli A. Acetylcholinesterase activity in suction biopsies of the rectum in the diagnosis of Hirschsprung's disease. J Pediatr Surg. 1972 Feb;7(1):11–17. doi: 10.1016/0022-3468(72)90394-6. [DOI] [PubMed] [Google Scholar]
  90. Merkler R. G., Solish S. B., Scherzer A. L. Meningomyelocele and Hirschprung disease: theoretical and clinical significance. Pediatrics. 1985 Aug;76(2):299–300. [PubMed] [Google Scholar]
  91. Michna B. A., McWilliams N. B., Krummel T. M., Hartenberg M. A., Salzberg A. M. Multifocal ganglioneuroblastoma coexistent with total colonic aganglionosis. J Pediatr Surg. 1988 Jan;23(1 Pt 2):57–59. doi: 10.1016/s0022-3468(88)80541-4. [DOI] [PubMed] [Google Scholar]
  92. Milbrandt J., de Sauvage F. J., Fahrner T. J., Baloh R. H., Leitner M. L., Tansey M. G., Lampe P. A., Heuckeroth R. O., Kotzbauer P. T., Simburger K. S. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 1998 Feb;20(2):245–253. doi: 10.1016/s0896-6273(00)80453-5. [DOI] [PubMed] [Google Scholar]
  93. Moore M. W., Klein R. D., Fariñas I., Sauer H., Armanini M., Phillips H., Reichardt L. F., Ryan A. M., Carver-Moore K., Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature. 1996 Jul 4;382(6586):76–79. doi: 10.1038/382076a0. [DOI] [PubMed] [Google Scholar]
  94. Moore S. W., Albertyn R., Cywes S. Clinical outcome and long-term quality of life after surgical correction of Hirschsprung's disease. J Pediatr Surg. 1996 Nov;31(11):1496–1502. doi: 10.1016/s0022-3468(96)90164-5. [DOI] [PubMed] [Google Scholar]
  95. Mowat D. R., Croaker G. D., Cass D. T., Kerr B. A., Chaitow J., Adès L. C., Chia N. L., Wilson M. J. Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: delineation of a new syndrome and identification of a locus at chromosome 2q22-q23. J Med Genet. 1998 Aug;35(8):617–623. doi: 10.1136/jmg.35.8.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Mulligan L. M., Eng C., Attié T., Lyonnet S., Marsh D. J., Hyland V. J., Robinson B. G., Frilling A., Verellen-Dumoulin C., Safar A. Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. Hum Mol Genet. 1994 Dec;3(12):2163–2167. doi: 10.1093/hmg/3.12.2163. [DOI] [PubMed] [Google Scholar]
  97. Mulligan L. M., Kwok J. B., Healey C. S., Elsdon M. J., Eng C., Gardner E., Love D. R., Mole S. E., Moore J. K., Papi L. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993 Jun 3;363(6428):458–460. doi: 10.1038/363458a0. [DOI] [PubMed] [Google Scholar]
  98. Myers S. M., Salomon R., Goessling A., Pelet A., Eng C., von Deimling A., Lyonnet S., Mulligan L. M. Investigation of germline GFR alpha-1 mutations in Hirschsprung disease. J Med Genet. 1999 Mar;36(3):217–220. [PMC free article] [PubMed] [Google Scholar]
  99. Mäkitie O., Kaitila I. Cartilage-hair hypoplasia--clinical manifestations in 108 Finnish patients. Eur J Pediatr. 1993 Mar;152(3):211–217. doi: 10.1007/BF01956147. [DOI] [PubMed] [Google Scholar]
  100. N-Fékété C., Ricour C., Martelli H., Jacob S. L., Pellerin D. Total colonic aganglionosis (with or without ileal involvement): a review of 27 cases. J Pediatr Surg. 1986 Mar;21(3):251–254. doi: 10.1016/s0022-3468(86)80847-8. [DOI] [PubMed] [Google Scholar]
  101. Neilson I. R., Yazbeck S. Ultrashort Hirschsprung's disease: myth or reality. J Pediatr Surg. 1990 Nov;25(11):1135–1138. doi: 10.1016/0022-3468(90)90748-x. [DOI] [PubMed] [Google Scholar]
  102. Newbern W. R. Hirschsprung's disease--the Duhamel modification. Am J Gastroenterol. 1967 Jan;47(1):61–68. [PubMed] [Google Scholar]
  103. Okamoto N., Wada Y., Goto M. Hydrocephalus and Hirschsprung's disease in a patient with a mutation of L1CAM. J Med Genet. 1997 Aug;34(8):670–671. doi: 10.1136/jmg.34.8.670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Parc R., Berrod J. L., Tussiot J., Loygue J. Le mégacôlon de l'adulte. A propos de 76 cas. Ann Gastroenterol Hepatol (Paris) 1984 May-Jun;20(3):133–141. [PubMed] [Google Scholar]
  105. Pasini B., Borrello M. G., Greco A., Bongarzone I., Luo Y., Mondellini P., Alberti L., Miranda C., Arighi E., Bocciardi R. Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet. 1995 May;10(1):35–40. doi: 10.1038/ng0595-35. [DOI] [PubMed] [Google Scholar]
  106. Passarge E. The genetics of Hirschsprung's disease. Evidence for heterogeneous etiology and a study of sixty-three families. N Engl J Med. 1967 Jan 19;276(3):138–143. doi: 10.1056/NEJM196701192760303. [DOI] [PubMed] [Google Scholar]
  107. Patterson K., Toomey K. E., Chandra R. S. Hirschsprung disease in a 46,XY phenotypic infant girl with Smith-Lemli-Opitz syndrome. J Pediatr. 1983 Sep;103(3):425–427. doi: 10.1016/s0022-3476(83)80422-3. [DOI] [PubMed] [Google Scholar]
  108. Pelet A., Geneste O., Edery P., Pasini A., Chappuis S., Atti T., Munnich A., Lenoir G., Lyonnet S., Billaud M. Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest. 1998 Mar 15;101(6):1415–1423. doi: 10.1172/JCI375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Peretz H., Luboshitsky R., Baron E., Biton A., Gershoni R., Usher S., Grynberg E., Yakobson E., Graff E., Lapidot M. Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting. Hum Mutat. 1997;10(2):155–159. doi: 10.1002/(SICI)1098-1004(1997)10:2<155::AID-HUMU7>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  110. Pichel J. G., Shen L., Sheng H. Z., Granholm A. C., Drago J., Grinberg A., Lee E. J., Huang S. P., Saarma M., Hoffer B. J. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 1996 Jul 4;382(6586):73–76. doi: 10.1038/382073a0. [DOI] [PubMed] [Google Scholar]
  111. Pingault V., Bondurand N., Kuhlbrodt K., Goerich D. E., Préhu M. O., Puliti A., Herbarth B., Hermans-Borgmeyer I., Legius E., Matthijs G. SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet. 1998 Feb;18(2):171–173. doi: 10.1038/ng0298-171. [DOI] [PubMed] [Google Scholar]
  112. Potterf S. B., Furumura M., Dunn K. J., Arnheiter H., Pavan W. J. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3. Hum Genet. 2000 Jul;107(1):1–6. doi: 10.1007/s004390000328. [DOI] [PubMed] [Google Scholar]
  113. Puffenberger E. G., Hosoda K., Washington S. S., Nakao K., deWit D., Yanagisawa M., Chakravart A. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell. 1994 Dec 30;79(7):1257–1266. doi: 10.1016/0092-8674(94)90016-7. [DOI] [PubMed] [Google Scholar]
  114. Puffenberger E. G., Kauffman E. R., Bolk S., Matise T. C., Washington S. S., Angrist M., Weissenbach J., Garver K. L., Mascari M., Ladda R. Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22. Hum Mol Genet. 1994 Aug;3(8):1217–1225. doi: 10.1093/hmg/3.8.1217. [DOI] [PubMed] [Google Scholar]
  115. Radetti G., Frick R., Pasquino B., Mengarda G., Savage M. O. Hypothalamic-pituitary dysfunction and Hirschsprung's disease in the Bardet-Biedl syndrome. Helv Paediatr Acta. 1988 Nov;43(3):249–252. [PubMed] [Google Scholar]
  116. Reish O., Gorlin R. J., Hordinsky M., Rest E. B., Burke B., Berry S. A. Brain anomalies, retardation of mentality and growth, ectodermal dysplasia, skeletal malformations, Hirschsprung disease, ear deformity and deafness, eye hypoplasia, cleft palate, cryptorchidism, and kidney dysplasia/hypoplasia (BRESEK/BRESHECK): new X-linked syndrome? Am J Med Genet. 1997 Feb 11;68(4):386–390. doi: 10.1002/(sici)1096-8628(19970211)68:4<386::aid-ajmg2>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  117. Reynolds J. F., Barber J. C., Alford B. A., Chandler J. G., Kelly T. E. Familial Hirschsprung's disease and type D brachydactyly: a report of four affected males in two generations. Pediatrics. 1983 Feb;71(2):246–249. [PubMed] [Google Scholar]
  118. Romeo G., Ceccherini I., Celli J., Priolo M., Betsos N., Bonardi G., Seri M., Yin L., Lerone M., Jasonni V. Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Intern Med. 1998 Jun;243(6):515–520. doi: 10.1046/j.1365-2796.1998.00332.x. [DOI] [PubMed] [Google Scholar]
  119. Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Käriäinen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994 Jan 27;367(6461):377–378. doi: 10.1038/367377a0. [DOI] [PubMed] [Google Scholar]
  120. Rosenthal A. The GDNF protein family: gene ablation studies reveal what they really do and how. Neuron. 1999 Feb;22(2):201–203. doi: 10.1016/s0896-6273(00)81077-6. [DOI] [PubMed] [Google Scholar]
  121. Roshkow J. E., Haller J. O., Berdon W. E., Sane S. M. Hirschsprung's disease, Ondine's curse, and neuroblastoma--manifestations of neurocristopathy. Pediatr Radiol. 1988;19(1):45–49. doi: 10.1007/BF02388410. [DOI] [PubMed] [Google Scholar]
  122. Russell M. B., Russell C. A., Niebuhr E. An epidemiological study of Hirschsprung's disease and additional anomalies. Acta Paediatr. 1994 Jan;83(1):68–71. doi: 10.1111/j.1651-2227.1994.tb12955.x. [DOI] [PubMed] [Google Scholar]
  123. Ryan E. T., Ecker J. L., Christakis N. A., Folkman J. Hirschsprung's disease: associated abnormalities and demography. J Pediatr Surg. 1992 Jan;27(1):76–81. doi: 10.1016/0022-3468(92)90111-j. [DOI] [PubMed] [Google Scholar]
  124. Sakai T., Wakizaka A., Matsuda H., Nirasawa Y., Itoh Y. Point mutation in exon 12 of the receptor tyrosine kinase proto-oncogene RET in Ondine-Hirschsprung syndrome. Pediatrics. 1998 May;101(5):924–926. doi: 10.1542/peds.101.5.924. [DOI] [PubMed] [Google Scholar]
  125. Sakai T., Wakizaka A., Nirasawa Y., Ito Y. Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome. Tohoku J Exp Med. 1999 Jan;187(1):43–47. doi: 10.1620/tjem.187.43. [DOI] [PubMed] [Google Scholar]
  126. Sakurai T., Yanagisawa M., Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992 Mar;13(3):103–108. doi: 10.1016/0165-6147(92)90038-8. [DOI] [PubMed] [Google Scholar]
  127. Salomon R., Attié T., Pelet A., Bidaud C., Eng C., Amiel J., Sarnacki S., Goulet O., Ricour C., Nihoul-Fékété C. Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet. 1996 Nov;14(3):345–347. doi: 10.1038/ng1196-345. [DOI] [PubMed] [Google Scholar]
  128. Santoro M., Carlomagno F., Romano A., Bottaro D. P., Dathan N. A., Grieco M., Fusco A., Vecchio G., Matoskova B., Kraus M. H. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 1995 Jan 20;267(5196):381–383. doi: 10.1126/science.7824936. [DOI] [PubMed] [Google Scholar]
  129. Santos H., Mateus J., Leal M. J. Hirschsprung disease associated with polydactyly, unilateral renal agenesis, hypertelorism, and congenital deafness: a new autosomal recessive syndrome. J Med Genet. 1988 Mar;25(3):204–205. doi: 10.1136/jmg.25.3.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Sarioglu A., Tanyel F. C., Büyükpamukçu N., Hiçsönmez A. Hirschsprung-associated congenital anomalies. Eur J Pediatr Surg. 1997 Dec;7(6):331–337. doi: 10.1055/s-2008-1071186. [DOI] [PubMed] [Google Scholar]
  131. Sayed M., al-Alaiyan S. Agenesis of corpus callosum, hypertrophic pyloric stenosis and Hirschsprung disease: coincidence or common etiology? Neuropediatrics. 1996 Aug;27(4):204–206. doi: 10.1055/s-2007-973789. [DOI] [PubMed] [Google Scholar]
  132. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994 Jan 27;367(6461):380–383. doi: 10.1038/367380a0. [DOI] [PubMed] [Google Scholar]
  133. Seri M., Yin L., Barone V., Bolino A., Celli I., Bocciardi R., Pasini B., Ceccherini I., Lerone M., Kristoffersson U. Frequency of RET mutations in long- and short-segment Hirschsprung disease. Hum Mutat. 1997;9(3):243–249. doi: 10.1002/(SICI)1098-1004(1997)9:3<243::AID-HUMU5>3.0.CO;2-8. [DOI] [PubMed] [Google Scholar]
  134. Slavotinek A. M., Stone E. M., Mykytyn K., Heckenlively J. R., Green J. S., Heon E., Musarella M. A., Parfrey P. S., Sheffield V. C., Biesecker L. G. Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet. 2000 Sep;26(1):15–16. doi: 10.1038/79116. [DOI] [PubMed] [Google Scholar]
  135. Soave F. Hirschsprung's disease. Technique and results of Soave's operation. Br J Surg. 1966 Dec;53(12):1023–1027. doi: 10.1002/bjs.1800531204. [DOI] [PubMed] [Google Scholar]
  136. Southard-Smith E. M., Angrist M., Ellison J. S., Agarwala R., Baxevanis A. D., Chakravarti A., Pavan W. J. The Sox10(Dom) mouse: modeling the genetic variation of Waardenburg-Shah (WS4) syndrome. Genome Res. 1999 Mar;9(3):215–225. [PubMed] [Google Scholar]
  137. Southard-Smith E. M., Kos L., Pavan W. J. Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat Genet. 1998 Jan;18(1):60–64. doi: 10.1038/ng0198-60. [DOI] [PubMed] [Google Scholar]
  138. Sparkes R. S., Sparkes M. C., Kalina R. E., Pagon R. A., Salk D. J., Disteche C. M. Separation of retinoblastoma and esterase D loci in a patient with sporadic retinoblastoma and del(13)(q14.1q22.3). Hum Genet. 1984;68(3):258–259. doi: 10.1007/BF00418397. [DOI] [PubMed] [Google Scholar]
  139. Spouge D., Baird P. A. Hirschsprung disease in a large birth cohort. Teratology. 1985 Oct;32(2):171–177. doi: 10.1002/tera.1420320204. [DOI] [PubMed] [Google Scholar]
  140. Stone D. L., Slavotinek A., Bouffard G. G., Banerjee-Basu S., Baxevanis A. D., Barr M., Biesecker L. G. Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat Genet. 2000 May;25(1):79–82. doi: 10.1038/75637. [DOI] [PubMed] [Google Scholar]
  141. Sulisalo T., Sistonen P., Hästbacka J., Wadelius C., Mäkitie O., de la Chapelle A., Kaitila I. Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nat Genet. 1993 Apr;3(4):338–341. doi: 10.1038/ng0493-338. [DOI] [PubMed] [Google Scholar]
  142. Swenson O. Early history of the therapy of Hirschsprung's disease: facts and personal observations over 50 years. J Pediatr Surg. 1996 Aug;31(8):1003–1008. doi: 10.1016/s0022-3468(96)90074-3. [DOI] [PubMed] [Google Scholar]
  143. Sánchez M. P., Silos-Santiago I., Frisén J., He B., Lira S. A., Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 1996 Jul 4;382(6586):70–73. doi: 10.1038/382070a0. [DOI] [PubMed] [Google Scholar]
  144. Taraviras S., Pachnis V. Development of the mammalian enteric nervous system. Curr Opin Genet Dev. 1999 Jun;9(3):321–327. doi: 10.1016/s0959-437x(99)80048-3. [DOI] [PubMed] [Google Scholar]
  145. Touraine R. L., Attié-Bitach T., Manceau E., Korsch E., Sarda P., Pingault V., Encha-Razavi F., Pelet A., Augé J., Nivelon-Chevallier A. Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet. 2000 Apr 4;66(5):1496–1503. doi: 10.1086/302895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Treanor J. J., Goodman L., de Sauvage F., Stone D. M., Poulsen K. T., Beck C. D., Gray C., Armanini M. P., Pollock R. A., Hefti F. Characterization of a multicomponent receptor for GDNF. Nature. 1996 Jul 4;382(6586):80–83. doi: 10.1038/382080a0. [DOI] [PubMed] [Google Scholar]
  147. Tsuji H., Spitz L., Kiely E. M., Drake D. P., Pierro A. Management and long-term follow-up of infants with total colonic aganglionosis. J Pediatr Surg. 1999 Jan;34(1):158–162. doi: 10.1016/s0022-3468(99)90248-8. [DOI] [PubMed] [Google Scholar]
  148. Van Camp G., Van Thienen M. N., Handig I., Van Roy B., Rao V. S., Milunsky A., Read A. P., Baldwin C. T., Farrer L. A., Bonduelle M. Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q. J Med Genet. 1995 Jul;32(7):531–536. doi: 10.1136/jmg.32.7.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Verdy M., Weber A. M., Roy C. C., Morin C. L., Cadotte M., Brochu P. Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr. 1982;1(4):603–607. doi: 10.1097/00005176-198212000-00027. [DOI] [PubMed] [Google Scholar]
  150. Verloes A., Elmer C., Lacombe D., Heinrichs C., Rebuffat E., Demarquez J. L., Moncla A., Adam E. Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature. Eur J Pediatr. 1993 Jan;152(1):75–77. doi: 10.1007/BF02072522. [DOI] [PubMed] [Google Scholar]
  151. WAARDENBURG P. J. A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Genet. 1951 Sep;3(3):195–253. [PMC free article] [PubMed] [Google Scholar]
  152. Wakamatsu N., Yamada Y., Yamada K., Ono T., Nomura N., Taniguchi H., Kitoh H., Mutoh N., Yamanaka T., Mushiake K. Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet. 2001 Apr;27(4):369–370. doi: 10.1038/86860. [DOI] [PubMed] [Google Scholar]
  153. Wassif C. A., Maslen C., Kachilele-Linjewile S., Lin D., Linck L. M., Connor W. E., Steiner R. D., Porter F. D. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am J Hum Genet. 1998 Jul;63(1):55–62. doi: 10.1086/301936. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Waterham H. R., Wijburg F. A., Hennekam R. C., Vreken P., Poll-The B. T., Dorland L., Duran M., Jira P. E., Smeitink J. A., Wevers R. A. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet. 1998 Aug;63(2):329–338. doi: 10.1086/301982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Weese-Mayer D. E., Silvestri J. M., Marazita M. L., Hoo J. J. Congenital central hypoventilation syndrome: inheritance and relation to sudden infant death syndrome. Am J Med Genet. 1993 Sep 1;47(3):360–367. doi: 10.1002/ajmg.1320470313. [DOI] [PubMed] [Google Scholar]
  156. Weinberg A. G., Currarino G., Besserman A. M. Hirschsprung's disease and congenital deafness. Familial assocation. Hum Genet. 1977 Sep 22;38(2):157–161. doi: 10.1007/BF00527397. [DOI] [PubMed] [Google Scholar]
  157. Whalen T. V., Jr, Asch M. J. Report of two patients with hypertrophic pyloric stenosis and Hirschsprung's disease. Coincident or common etiology? Am Surg. 1985 Aug;51(8):480–481. [PubMed] [Google Scholar]
  158. Yanagisawa H., Yanagisawa M., Kapur R. P., Richardson J. A., Williams S. C., Clouthier D. E., de Wit D., Emoto N., Hammer R. E. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development. 1998 Mar;125(5):825–836. doi: 10.1242/dev.125.5.825. [DOI] [PubMed] [Google Scholar]
  159. Yanchar N. L., Soucy P. Long-term outcome after Hirschsprung's disease: patients' perspectives. J Pediatr Surg. 1999 Jul;34(7):1152–1160. doi: 10.1016/s0022-3468(99)90588-2. [DOI] [PubMed] [Google Scholar]
  160. al-Gazali L. I., Donnai D., Mueller R. F. Hirschsprung's disease, hypoplastic nails, and minor dysmorphic features: a distinct autosomal recessive syndrome? J Med Genet. 1988 Nov;25(11):758–761. doi: 10.1136/jmg.25.11.758. [DOI] [PMC free article] [PubMed] [Google Scholar]